IL 16, (130 a.a.) Recombinant Protein
Source : Escherichia Coli. Interleukin-16 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 130 amino acids and having a molecular mass of 13.5 kDa. The IL-16 is purified by proprietary chromatographic techniques. IL-16 is a pleiotropic cytokine that functions as a chemoattractant, a modulator of T cell activation, and an inhibitor of HIV replication. The signaling process of IL-16 is mediated by CD4. The product of this gene undergoes proteolytic processing, which is found to yield two functional proteins. IL-16 functions exclusively attributed to the secreted C-terminal peptide, while the N-terminal product may play a role in cell cycle control. Caspase 3 is reported to be involved in the proteolytic processing of this protein. Two transcript variants encoding different isoforms have been found for this gene.IL-16 stimulates a migratory response in cd4+ lymphocytes, monocytes, and eosinophils. Also induces t-lymphocyte expression of interleukin 2 receptor, ligand for cd4.
Product Specifications
Product Name Alternative
IL16||Interleukin-16||LCF||Lymphocyte Chemoattractant Factor||prIL-16||IL-16||FLJ16806||FLJ42735||FLJ44234||HsT19289.
Purification
Greater than 90.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis SDS-PAGE.
Components
IL-16 was lyophilized at 1 mg/mL in 10mM NaP, pH-7.5.
Storage Conditions
Applications Notes
Amino Acids
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Pro-Asp-Leu-Asn.
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items